The diabetes drug Avandia has been reported to have serious health risks to patients who take this drug. As many of you know, one of our favorite blogs is the Consumerist and they have an excellent post today about what, and when, the FDA knew about the risk to patients using this drug. Here is an excerpt:
The maker of the drug, GlaxoSmithKline, separately told the FDA of the risk last August, but neither the drug maker nor the Agency warned the public.
The study was outed yesterday on the New England Journal of Medicine’s website. The editors of the journal and the study’s lead author both warned that the research methodology left the “findings open to interpretation.”
Even though the FDA was aware of the risks since last summer,
…the publication of the study on the journal’s Web site prompted the Food and Drug Administration to issue a public safety alert and advise users of the drug — an estimated million people in this country and two million worldwide — to consult their doctors about the potential cardiovascular risks.
Congress wants to know why the FDA can’t walk and chew gum . . . .
This is a very serious matter and you may want to consult with your doctor about the health risks. If you have any legal questions about this, please consult with your attorney.
Another resource for you is to join our Facebook Fan Page – Alabama Consumer Protection Attorneys where we share useful information about the same types of issues that we cover in this blog.